Bios Equity Partners, LP - Insider Non-Derivative Transactions at Lantern Pharma Inc. (LTRN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 29, 2023, Bios Equity Partners, LP's relationship to Lantern Pharma Inc. (LTRN) is TenPercentOwner, and currently has 371,950 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LTRN insiders.
Data Source: SEC.
Bios Equity Partners, LP - Insider Non-Derivative Transactions at LTRN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 30, 2023 | Sell -- (Common Stock) | 53640 | 3.44 | 217553 |
| Nov 30, 2023 | Sell -- (Common Stock) | 91708 | 3.44 | 371950 |